Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 EUR ↑0,24 (3,28%)
2026-06-05
PREȚUL ACȚIUNILOR
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership53,995 shares
Latest Disclosed Value $ 438,979
Citigroup Inc reports 83.58% increase in ownership of KUR / Kura Oncology, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 53,995 shares of Kura Oncology, Inc. (DE:KUR) valued at $359,067 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 29,412 shares of Kura Oncology, Inc.. This represents a change in shares of 83.58% during the quarter. The current value of the position is $408,202 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F KURA ONCOLOGY COM 50127T109 53,995 24,583 83.58 439 43.61 0.0001
2026-02-13 2025-12-31 13F KURA ONCOLOGY COM 50127T109 29,412 -265,611 -90.03 306 -88.31 0.0001
2025-11-10 2025-09-30 13F KURA ONCOLOGY COM 50127T109 295,023 10,845 3.82 2,611 59.24 0.0012
2025-08-11 2025-06-30 13F KURA ONCOLOGY COM 50127T109 284,178 127,993 81.95 1,640 59.13 0.0008
2025-05-12 2025-03-31 13F KURA ONCOLOGY COM 50127T109 156,185 30,271 24.04 1,031 -6.02 0.0005
2025-02-12 2024-12-31 13F KURA ONCOLOGY COM 50127T109 125,914 60,904 93.68 1,097 -13.70 0.0007
2024-11-12 2024-09-30 13F KURA ONCOLOGY COM 50127T109 65,010 31,677 95.03 1,270 85.13 0.0007
2024-08-12 2024-06-30 13F KURA ONCOLOGY COM 50127T109 33,333 -238,563 -87.74 686 -88.17 0.0004
2024-05-10 2024-03-31 13F KURA ONCOLOGY COM 50127T109 271,896 203,663 298.48 5,800 491.13 0.0038
2024-02-09 2023-12-31 13F KURA ONCOLOGY COM 50127T109 68,233 -30,324 -30.77 981 9.24 0.0007
2023-12-06 2023-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 98,557 22,357 29.34 899 11.41 0.0007
2023-11-09 2023-09-30 13F KURA ONCOLOGY COM 50127T109 98,557 22,357 899 0.0003
2023-08-10 2023-06-30 13F KURA ONCOLOGY COM 50127T109 76,200 -144,788 -65.52 806 -70.17 0.0005
2023-05-11 2023-03-31 13F KURA ONCOLOGY COM 50127T109 220,988 76,397 52.84 2,703 50.61 0.0019
2023-02-09 2022-12-31 13F KURA ONCOLOGY COM 50127T109 144,591 -112,867 -43.84 1,794 -48.99 0.0014
2022-11-10 2022-09-30 13F KURA ONCOLOGY COM 50127T109 257,458 158,822 161.02 3,517 94.52 0.0025
2022-08-10 2022-06-30 13F KURA ONCOLOGY COM 50127T109 98,636 66,032 202.53 1,808 244.38 0.0013
2022-05-12 2022-03-31 13F KURA ONCOLOGY COM 50127T109 32,604 -141,330 -81.25 525 -78.44 0.0003
2022-02-10 2021-12-31 13F KURA ONCOLOGY COM 50127T109 173,934 20,551 13.40 2,435 -15.25 0.0013
2021-11-10 2021-09-30 13F KURA ONCOLOGY COM 50127T109 153,383 -29,285 -16.03 2,873 -24.57 0.0017
2021-08-10 2021-06-30 13F KURA ONCOLOGY COM 50127T109 182,668 39,614 27.69 3,809 -5.81 0.0023
2021-05-13 2021-03-31 13F KURA ONCOLOGY COM 50127T109 143,054 128,371 874.28 4,044 742.50 0.0026
2021-02-11 2020-12-31 13F KURA ONCOLOGY COM 50127T109 14,683 10,096 220.10 480 240.43 0.0003
2020-11-12 2020-09-30 13F KURA ONCOLOGY COM 50127T109 4,587 -26,212 -85.11 141 -71.91 0.0001
2020-08-12 2020-06-30 13F KURA ONCOLOGY COM 50127T109 30,799 9,001 41.29 502 131.34 0.0004
2020-05-12 2020-03-31 13F KURA ONCOLOGY COM 50127T109 21,798 8,893 68.91 217 22.60 0.0002
2020-02-12 2019-12-31 13F KURA ONCOLOGY COM 50127T109 12,905 -25,681 -66.56 177 -69.74 0.0001
2019-11-08 2019-09-30 13F KURA ONCOLOGY COM 50127T109 38,586 -1,187 -2.98 585 -25.29 0.0005
2019-08-12 2019-06-30 13F KURA ONCOLOGY COM 50127T109 39,773 -225 -0.56 783 17.92 0.0006
2019-05-13 2019-03-31 13F KURA ONCOLOGY COM 50127T109 39,998 -71,979 -64.28 664 -57.76 0.0006
2019-02-12 2018-12-31 13F KURA ONCOLOGY COM 50127T109 111,977 63,241 129.76 1,572 84.29 0.0016
2018-11-13 2018-09-30 13F KURA ONCOLOGY COM 50127T109 48,736 19,229 65.17 853 58.85 0.0008
2018-08-10 2018-06-30 13F KURA ONCOLOGY COM 50127T109 29,507 2,893 10.87 537 7.62 0.0005
2018-05-11 2018-03-31 13F KURA ONCOLOGY COM 50127T109 26,614 17,029 177.66 499 239.46 0.0004
2018-02-12 2017-12-31 13F KURA ONCOLOGY COM 50127T109 9,585 2,925 43.92 147 47.00 0.0001
2017-11-13 2017-09-30 13F KURA ONCOLOGY COM 50127T109 6,660 -985 -12.88 100 40.85 0.0001
2017-08-11 2017-06-30 13F KURA ONCOLOGY COM 50127T109 7,645 495 6.92 71 12.70 0.0001
2017-05-12 2017-03-31 13F KURA ONCOLOGY COM 50127T109 7,150 1,500 26.55 63 90.91 0.0001
2017-02-10 2016-12-31 13F KURA ONCOLOGY COM 50127T109 5,650 0 0.00 33 -5.71 0.0000
2016-11-10 2016-09-30 13F KURA ONCOLOGY COM 50127T109 5,650 300 5.61 35 150.00 0.0000
2016-08-12 2016-06-30 13F KURA ONCOLOGY COM 50127T109 5,350 1,400 35.44 14 -12.50 0.0000
2016-05-13 2016-03-31 13F KURA ONCOLOGY COM 50127T109 3,950 3,950 16 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.